Invesco
CADX

Invesco’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Invesco’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-882,119
Closed -$7.98M – 4432
2013
Q4 		$7.98M Buy
+882,119
New +$6.37M ﹤0.01% 1701
2013
Q3 		– Sell
-670,485
Closed -$4.57M – 4381
2013
Q2 		$4.57M Buy
+670,485
New +$4.67M ﹤0.01% 1900

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco's CADX Position: Q1 2014 in Review

Invesco sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 882,119 shares — an estimated $7.98M sold.

Invesco first reported a position in CADX in Q2 2013 and held it in 2 quarters. The position peaked at $7.98M in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Invesco reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Invesco sold 882,119 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $7.98M.
  • Invesco first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 2 quarters.
  • Invesco's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $7.98M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Invesco's 13F filing for Q1 2014, filed 15 May 2014.